Showing results (241-250 of 432) with videos related to
Sort By:
Pageof 44
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signalingDouglas J Sheffler, Wesley K Kroeze, Bonnie G Garcia, et al.ACS Chemical Biology|March 15, 2013
Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptorDahlia R Weiss, SeungKirl Ahn, Maria F Sassano, et al.Cell Reports|September 10, 2013
DREADDs in Drosophila: a pharmacogenetic approach for controlling behavior, neuronal signaling, and physiology in the flyJaime Becnel, Oralee Johnson, Zana R Majeed, et al.Science Translational Medicine|May 8, 2024
MRGPRX4 mediates phospho-drug-associated pruritus in a humanized mouse modelDaphne Chun-Che Chien, Nathachit Limjunyawong, Can Cao, et al.Journal of Medicinal Chemistry|October 23, 2013
4β-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4β-methyl-5-(3-hydroxyphenyl)morphan pure antagonistF Ivy Carroll, Moses G Gichinga, John D Williams, et al.Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligandsMarco De Amici, Paola Conti, Ezio Fasoli, et al.Molecular Pharmacology|July 17, 2008
New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug)Vindhya Nawaratne, Katie Leach, Nur Suratman, et al.The Journal of Biological Chemistry|October 15, 2013
Chemotype-selective modes of action of κ-opioid receptor agonistsEyal Vardy, Philip D Mosier, Kevin J Frankowski, et al.Proceedings of the National Academy of Sciences of the United States of America|June 20, 2012
Identifying mechanism-of-action targets for drugs and probesElisabet Gregori-Puigjané, Vincent Setola, Jérôme Hert, et al.Journal of Medicinal Chemistry|March 17, 2009
Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like actionSung Jin Cho, Niels H Jensen, Toru Kurome, et al.Pageof 44